Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Rani Therapeutics Holdings, Inc. | 123,600 | reported | 28 May 2026 | tx 13+599,690−233,398 |
| PFIZER INC | 47,345.77 | reported | 26 Apr 2018 | tx 12+53,732.78 |
| Seres Therapeutics, Inc. | 6,452 | reported | 01 Jul 2025 | tx 13+489,016 |
| ALNYLAM PHARMACEUTICALS, INC. | 1,582 | reported | 20 May 2026 | tx 85+278,759−287,343 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 28 May 2026 | GRANT_AWARD | Rani Therapeutics Holdings, Inc. | 123,600 | 0.00 USD | deriv |
| 20 May 2026 | GRANT_AWARD | ALNYLAM PHARMACEUTICALS, INC. | 671 | 0.00 USD | |
| 20 May 2026 | GRANT_AWARD | ALNYLAM PHARMACEUTICALS, INC. | 1,441 | 0.00 USD | deriv |
| 14 Aug 2025 | EXERCISE | ALNYLAM PHARMACEUTICALS, INC. | 9,000 | 72.01 USD | |
| 14 Aug 2025 | EXERCISE | ALNYLAM PHARMACEUTICALS, INC. | 5,153 | 128.31 USD | |
| 14 Aug 2025 | SALE | ALNYLAM PHARMACEUTICALS, INC. | 641 | 442.66 USD | |
| 14 Aug 2025 | EXERCISE | ALNYLAM PHARMACEUTICALS, INC. | 4,581 | 148.77 USD | |
| 14 Aug 2025 | EXERCISE | ALNYLAM PHARMACEUTICALS, INC. | 5,228 | 151.22 USD | |
| 14 Aug 2025 | EXERCISE | ALNYLAM PHARMACEUTICALS, INC. | 4,032 | 171.95 USD | |
| 14 Aug 2025 | EXERCISE | ALNYLAM PHARMACEUTICALS, INC. | 3,454 | 189.87 USD | |
| 14 Aug 2025 | SALE | ALNYLAM PHARMACEUTICALS, INC. | 1,985 | 430.81 USD | |
| 14 Aug 2025 | SALE | ALNYLAM PHARMACEUTICALS, INC. | 1,938 | 432.94 USD | |
| 14 Aug 2025 | SALE | ALNYLAM PHARMACEUTICALS, INC. | 2,098 | 434.50 USD | |
| 14 Aug 2025 | SALE | ALNYLAM PHARMACEUTICALS, INC. | 7,675 | 435.40 USD | |
| 14 Aug 2025 | SALE | ALNYLAM PHARMACEUTICALS, INC. | 5,358 | 436.00 USD | |
| 14 Aug 2025 | SALE | ALNYLAM PHARMACEUTICALS, INC. | 1,922 | 437.56 USD | |
| 14 Aug 2025 | SALE | ALNYLAM PHARMACEUTICALS, INC. | 2,086 | 438.34 USD | |
| 14 Aug 2025 | SALE | ALNYLAM PHARMACEUTICALS, INC. | 5,302 | 439.27 USD | |
| 14 Aug 2025 | SALE | ALNYLAM PHARMACEUTICALS, INC. | 1,238 | 440.54 USD | |
| 14 Aug 2025 | SALE | ALNYLAM PHARMACEUTICALS, INC. | 1,205 | 441.88 USD | |
| 14 Aug 2025 | EXERCISE | ALNYLAM PHARMACEUTICALS, INC. | 4,032 | 0.00 USD | deriv |
| 14 Aug 2025 | EXERCISE | ALNYLAM PHARMACEUTICALS, INC. | 5,228 | 0.00 USD | deriv |
| 14 Aug 2025 | EXERCISE | ALNYLAM PHARMACEUTICALS, INC. | 4,581 | 0.00 USD | deriv |
| 14 Aug 2025 | EXERCISE | ALNYLAM PHARMACEUTICALS, INC. | 5,153 | 0.00 USD | deriv |
| 14 Aug 2025 | EXERCISE | ALNYLAM PHARMACEUTICALS, INC. | 3,454 | 0.00 USD | deriv |